Citation:
Gamble J-M, Donnan JR, Chibrikov E, Twells LK, Midodzi WK, Majumdar SR. Diabetes Research and Clinical Practice. The risk of fragility fractures in new users of dipeptidyl peptidase-4 inhibitors compared to sulfonylureas and other anti-diabetic drugs: A cohort study [Internet]. 2018;Available from: http://www.scopus.com/inward/record.url?eid=2-s2.0-85039789313&partnerID=MN8TOARS